Eric J Weber

US Patent:

7183080, Feb 27, 2007

Filed:

Feb 24, 2004

Appl. No.:

10/787382

Inventors:

Shumin Yang - Palo Alto CA, US
Catherine A. McCall - Boulder CO, US
Eric R. Weber - Fort Collins CO, US

Assignee:

Heska Corporation - Loveland CO

International Classification:

C12P 21/06
C07H 21/02
C07H 21/04
C12N 5/00
C12N 15/00
C12N 15/63

US Classification:

435 691, 4353201, 435325, 435455, 536 231, 536 235

Abstract:

The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.

US Patent:

7234061, Jun 19, 2007

Filed:

Aug 10, 2001

Appl. No.:

09/927999

Inventors:

Wael Diab - Menlo Park CA, US
John McCool - Los Gatos CA, US
Eric Weber - San Jose CA, US
Anshul Sadana - Santa Clara CA, US

Assignee:

Cisco Technology, Inc. - San Jose CA

International Classification:

H04L 9/00
H04K 1/00

US Classification:

713176, 380 2

Abstract:

A technique verifies a that a module is from an approved vendor. The technique involves obtaining vendor data and a first magic code from a module (e. g. , a small form factor pluggable component), and generating a second magic code based on the vendor data. The technique further involves outputting (i) a magic code valid signal when the second magic code matches the first magic code, and (ii) a magic code invalid signal when the second magic code does not match the first magic code. Operation of a computerized device having the module can be based on the valid and invalid signals (e. g. , a voltage level, a bit that is set or cleared, a value in a register, etc. ). For example, a supplier of the electronic device can configure software running on the computerized device to disable the module if the first and second magic codes do not match.

US Patent:

7427661, Sep 23, 2008

Filed:

Nov 20, 2006

Appl. No.:

11/561562

Inventors:

Shumin Yang - Palo Alto CA, US
Catherine A. McCall - Boulder CO, US
Eric R. Weber - Fort Collins CO, US

Assignee:

Heska Corporation - Loveland CO

International Classification:

C07K 14/52
C12N 15/19

US Classification:

530351, 536 235, 435 695

Abstract:

The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.

US Patent:

20020127200, Sep 12, 2002

Filed:

Jan 5, 2001

Appl. No.:

09/755633

Inventors:

Shumin Yang - Palo Alto CA, US
Catherine McCall - Boulder CO, US
Eric Weber - Fort Collins CO, US

International Classification:

A61K039/395
A61K038/20
C07H021/04
C12P021/04
C12N005/06

US Classification:

424/085200, 424/145100, 530/351000, 536/023500, 435/069520, 435/320100, 435/325000

Abstract:

The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.

US Patent:

20060157127, Jul 20, 2006

Filed:

Jan 14, 2005

Appl. No.:

11/036713

Inventors:

Mark Bors - Grafton OH, US
Todd Loschelder - Macedonia OH, US
William Markowitz - Cleveland OH, US
Eric Weber - Medina OH, US
Alfred Schiazza - Avon Lake OH, US

International Classification:

E03C 1/04

US Classification:

137801000

Abstract:

In one embodiment, a swing spout is provided. The swing spout includes a spout hub and a bearing member. The spout hub is operable to rotate relative to the bearing member. The bearing member has a detent and the spout hub has a detent member. When the spout hub is rotated to a predetermined position, the detent member of the spout hub engages the detent of the bearing member.

US Patent:

20090111970, Apr 30, 2009

Filed:

Sep 19, 2008

Appl. No.:

12/234136

Inventors:

Shumin Yang - Palo Alto CA, US
Catherine A. McCall - Boulder CO, US
Eric R. Weber - Fort Collins CO, US

International Classification:

C07K 4/00
C07K 14/00

US Classification:

530324, 530326

Abstract:

The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.